RenalSense Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $835K
Latest Deal Amount
  • Investors
  • 2

RenalSense General Information


Developer of a critical care monitoring system intended for real-time renal diagnostics. The company platform continuously measures urine flow, automatically transmitting to the medical staff real-time data about changes in renal function and notifications of fluctuations, on a 24/7 basis, facilitating doctors with early detection of changes in renal function and AKI risk and enabling rapid intervention, better patient care and improved ICU economics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
  • 3 Hamarpe
  • Har Hotzvim, Post Office Box 45397
  • Jerusalem 9145101
  • Israel
+972 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RenalSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 30-May-2019 $835K 00.00 Completed Generating Revenue
1. Angel (individual) 31-Dec-2015 00.00 00.00 Completed Startup
To view RenalSense’s complete valuation and funding history, request access »

RenalSense Executive Team (5)

Name Title Board Seat Contact Info
Avi Kleiman Co-Founder, Chief Executive Officer & Chairman
Yohanan Engelhardt Chief Financial Officer
Moti Barda Chief Operating Officer
Joseph Kochba Vice President, Research & Development
Mor Grinstein Ph.D Co-Founder, Chief Medical Officer & Board Member
To view RenalSense’s complete executive team members history, request access »

RenalSense Board Members (4)

Name Representing Role Since
Avi Kleiman RenalSense Co-Founder, Chief Executive Officer & Chairman 000 0000
Cuong Do Self Board Member 000 0000
Milton Yisrael RenalSense Board Member 000 0000
Mor Grinstein Ph.D RenalSense Co-Founder, Chief Medical Officer & Board Member 000 0000
To view RenalSense’s complete board members history, request access »

RenalSense Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenalSense Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Israeli Ministry of Economy and Industry Government 000 0000 000000 0
Israel Innovation Authority Government 000 0000 000000 0
To view RenalSense’s complete investors history, request access »